Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-02-08
1993-12-28
Hill, Jr., Robert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530380, 530381, 514 2, 435 691, 435 693, C07K 1300, A61K 3702, C12N 1512, C12N 1515
Patent
active
052739627
ABSTRACT:
Recombinant thrombin-binding substances, derived from thrombomodulin by modification of the c-terminal glycosaminoglycan (GAG) binding site and capable of promoting anti-thrombin III activity and inhibiting platelet aggregation, and by themselves possessing anti-thrombin activity are disclosed. The thrombin-binding substances are useful as an effective component of anticoagulant agents, and can be produced inexpensively in a large scale.
REFERENCES:
Suzuki, K., et al. (1989) J. Biol. Chem. 264:4872-76.
Preissner, K. T., et al. (1990) J. Biol. Chem. 265:4915-22.
Nawa, K., et al. (1990) Biochem. Biophys. Res. Comm. 171:729-37.
Jackman, R. W., et al. (1987) Proc. Natl. Acad Sci. USA 84:6425-29.
Parkinson, J. F., et al. (1990) Biochem. Biophys. Res. Comm. 169:177-83.
Bourdon, M. A., et al. (1986) J. Biol. Chem. 261:12534-37.
Doi Takeshi
Iwasaki Akio
Kimura Shigeru
Ohkuchi Masao
Saino Yushi
Fitzgerald David L.
Hill Jr. Robert J.
Kowa Co. Ltd.
LandOfFree
Human urinary thrombomodulin with a modified glycosaminoglycan ( does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human urinary thrombomodulin with a modified glycosaminoglycan (, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human urinary thrombomodulin with a modified glycosaminoglycan ( will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1542704